Evolent Health, Inc. EVH Reportable segment — Interest Expense
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Evolent Health, Inc. in its filing.
Tagged under the XBRL concept us-gaap:InterestExpenseNonoperating.
The official record: Evolent Health, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Evolent Health, Inc.'s reportable segment — interest expense.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Evolent Health, Inc.'s reportable segment — interest expense?
- Evolent Health, Inc. (EVH) reported reportable segment — interest expense of $16.87M in Q1 2026.
- How has Evolent Health, Inc.'s reportable segment — interest expense changed year-over-year?
- Evolent Health, Inc.'s reportable segment — interest expense increased by 62.4% year-over-year, from $10.39M to $16.87M.
- What is the long-term trend for Evolent Health, Inc.'s reportable segment — interest expense?
- Over 3 years (2022 to 2025), Evolent Health, Inc.'s reportable segment — interest expense has grown at a 54.5% compound annual growth rate (CAGR), from $15.57M to $57.47M.
- What does reportable segment — interest expense mean?
- This captures the costs associated with the segment's debt obligations and financing arrangements. It is a key metric for evaluating the segment's financial leverage and the impact of debt servicing on overall profitability.